Global Chronic Kidney Disease Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Chronic Kidney Disease Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Chronic Kidney Disease Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Chronic Kidney Disease Drugs market is projected to reach US$ 12670 million in 2034, increasing from US$ 10880 million in 2022, with the CAGR of 1.8% during the period of 2024 to 2034. Demand from Hospitals and Specialty Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Chronic Kidney Disease Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Chronic Kidney Disease Drugs key manufacturers include Keryx Biopharmaceuticals, Inc, Kissei Pharmaceutical Co., Ltd, AbbVie, GlaxoSmithKline, Sanofi, F. Hoffmann-La Roche Ltd, Pfizer, AstraZeneca and Amgen, etc. Keryx Biopharmaceuticals, Inc, Kissei Pharmaceutical Co., Ltd, AbbVie are top 3 players and held % sales share in total in 2022.
Chronic Kidney Disease Drugs can be divided into ACE Inhibitors, Calcium Channel Blockers, Beta Blockers and Others, etc. ACE Inhibitors is the mainstream product in the market, accounting for % sales share globally in 2022.
Chronic Kidney Disease Drugs is widely used in various fields, such as Hospitals and Specialty Clinics, etc. Hospitals provides greatest supports to the Chronic Kidney Disease Drugs industry development. In 2022, global % sales of Chronic Kidney Disease Drugs went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chronic Kidney Disease Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Keryx Biopharmaceuticals, Inc
Kissei Pharmaceutical Co., Ltd
AbbVie
GlaxoSmithKline
Sanofi
F. Hoffmann-La Roche Ltd
Pfizer
AstraZeneca
Amgen
Teva Pharmaceutical Industries
Segment by Type
ACE Inhibitors
Calcium Channel Blockers
Beta Blockers
Others
Hospitals
Specialty Clinics
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Chronic Kidney Disease Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Chronic Kidney Disease Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Chronic Kidney Disease Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Chronic Kidney Disease Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Chronic Kidney Disease Drugs introduction, etc. Chronic Kidney Disease Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Chronic Kidney Disease Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Chronic Kidney Disease Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Chronic Kidney Disease Drugs key manufacturers include Keryx Biopharmaceuticals, Inc, Kissei Pharmaceutical Co., Ltd, AbbVie, GlaxoSmithKline, Sanofi, F. Hoffmann-La Roche Ltd, Pfizer, AstraZeneca and Amgen, etc. Keryx Biopharmaceuticals, Inc, Kissei Pharmaceutical Co., Ltd, AbbVie are top 3 players and held % sales share in total in 2022.
Chronic Kidney Disease Drugs can be divided into ACE Inhibitors, Calcium Channel Blockers, Beta Blockers and Others, etc. ACE Inhibitors is the mainstream product in the market, accounting for % sales share globally in 2022.
Chronic Kidney Disease Drugs is widely used in various fields, such as Hospitals and Specialty Clinics, etc. Hospitals provides greatest supports to the Chronic Kidney Disease Drugs industry development. In 2022, global % sales of Chronic Kidney Disease Drugs went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chronic Kidney Disease Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Keryx Biopharmaceuticals, Inc
Kissei Pharmaceutical Co., Ltd
AbbVie
GlaxoSmithKline
Sanofi
F. Hoffmann-La Roche Ltd
Pfizer
AstraZeneca
Amgen
Teva Pharmaceutical Industries
Segment by Type
ACE Inhibitors
Calcium Channel Blockers
Beta Blockers
Others
Segment by Application
Hospitals
Specialty Clinics
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Chronic Kidney Disease Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Chronic Kidney Disease Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Chronic Kidney Disease Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Chronic Kidney Disease Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Chronic Kidney Disease Drugs introduction, etc. Chronic Kidney Disease Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Chronic Kidney Disease Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices